Agenda Item 1130.16 REPORT Attachment 5 TRUST BOARD PUBLIC SESSION – Tuesday 6 September 2016 Subject: Update on Trust Mortality Prepared by: Dr Nick Lyons, Medical Director Approved by: Presented by: Dr Nick Medical Director Purpose Discussion The purpose of this report is to provide assurance to Members of the Trust Board that the findings of the Mortality Review Group are being implemented Approval and that there is now a more robust process for identifying learning from Information Mortality Reviews. Other Trust Objectives Safety Quality Efficiency Workforce Finance Governance Executive Summary The Mortality Review process now looks at 85% of cases (compared with less than 10% in September 2015). Cases are to ensure consistency of assessment and “double-reviewed” learning is now more effectively embedded in the clinical governance work of the Directorates. Key Recommendations The Trust Board will receive a brief report at the October Trust Board Seminar with the latest mortality data, to include the National Summary Hospital Mortality Indicator (SHMI) for the year to March 2016. Assurance Framework Through Directorate governance. Next Steps Actions as recommended and implemented by the Mortality Review Group and embedded within Directorate governance structures. Corporate Impact Assessment NHS Values Covers NHS Values CQC Regulations As detailed within the report Financial Implications N/A N/A Legal Implications As detailed within the report Equality & Diversity
REPORT Agenda Item 1130.16 Attachment 5 TRUST BOARD – PUBLIC SESSION Tuesday 6 September 2016 Subject: Update on Trust Mortality Prepared by: Dr Nick Lyons, Medical Director Approved by: Presented by: Dr Nick Medical Director Purpose The purpose of this report is to provide assurance to Members of the Trust Board that the findings of the Mortality Review Group are being implemented and that there is now a more robust process for identifying learning from Mortality Reviews. Discussion Approval Information Other Trust Objectives Safety Quality Efficiency Workforce Finance Governance Executive Summary The Mortality Review process now looks at 85% of cases (compared with less than 10% in September 2015). Cases are “double-reviewed” to ensure consistency of assessment and learning is now more effectively embedded in the clinical governance work of the Directorates. Key Recommendations The Trust Board will receive a brief report at the October Trust Board Seminar with the latest mortality data, to include the National Summary Hospital Mortality Indicator (SHMI) for the year to March 2016. Assurance Framework Through Directorate governance. Next Steps Actions as recommended and implemented by the Mortality Review Group and embedded within Directorate governance structures. Corporate Impact Assessment NHS Values Covers NHS Values CQC Regulations As detailed within the report Financial Implications N/A Legal Implications N/A Equality & Diversity As detailed within the report
Agenda%20Item%201130%2016%20%20Update%20on%20Trust%20Mortality.docx